Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
8.07
+1.03 (14.63%)
At close: Mar 6, 2026, 4:00 PM EST
9.35
+1.28 (15.86%)
After-hours: Mar 6, 2026, 7:59 PM EST
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $666.36 million as of March 6, 2026. Its market cap has decreased by -37.21% in one year.
Market Cap
666.36M
Enterprise Value
473.57M
1-Year Change
-37.21%
Ranking
Category
Stock Price
$8.07
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $666.36M, an increase of 42.53%. That is a compound annual growth rate of 4.75%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Tau Medical | 607.08M |
| Vor Biopharma | 604.53M |
| LB Pharmaceuticals | 599.34M |
| YD Bio | 589.17M |
| enGene Holdings | 583.48M |
| Design Therapeutics | 574.76M |
| Ocugen | 570.53M |
| Larimar Therapeutics | 566.84M |